Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
Yahoo Finance
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance